Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Treatment of Postoperative Pain After Total Hip Arthroplasty Using Intravenous Lidocaine Infusion

This study has been withdrawn prior to enrollment.
Charles Lee MD
Michelle Schlunt MD
Information provided by (Responsible Party):
Loma Linda University Identifier:
First received: April 20, 2010
Last updated: April 2, 2015
Last verified: April 2015
This study will focus on patients undergoing total hip arthroplasty and Loma Linda University Medical Center & East Campus. These patients will be randomized to receive a low dose lidocaine infusion or placebo, in addition to the patient controlled analgesia pump. These groups will be compared to one another statistically to determine which group shows the safest and most satisfying pain control.

Condition Intervention Phase
Postoperative Pain Management After Total Hip Arthroplasty
Drug: Lidocaine
Other: Normal Saline
Phase 1
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Masking: Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Treatment of Postoperative Pain After Total Hip Arthroplasty Using Intravenous Lidocaine Infusion in Combination With Patient Controlled Analgesia: a Prospective Randomized, Double-blinded, Placebo-controlled Study

Resource links provided by NLM:

Further study details as provided by Loma Linda University:

Primary Outcome Measures:
  • We propose to test the hypothesis that adding a low dose lidocaine infusion to patient controlled analgesia will lower the amount of opioids that these patients will receive, thereby improving patient safety while still providing adequate analgesia. [ Time Frame: 24 hours ]

Enrollment: 0
Study Start Date: February 2008
Estimated Primary Completion Date: August 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Placebo Comparator: Control Group
Patients will receive a Dilaudid PCA in combination with a placebo infusion of normal saline.
Other: Normal Saline
Patients in the control group will be receiving an infusion of normal saline for 24 hours postoperatively.
Experimental: Lidocaine Group
Patients will be receive a Dilaudid PCA in combination with a continuous Lidocaine infusion.
Drug: Lidocaine
Patients in the experimental group will be receiving a Lidocaine infusion at 1.33 mg/kg/hr for 24 hours postoperatively.


Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Adult male or female undergoing a total hip arthroplasty Subject is American Society of Anesthesiologists physical status 1, 2, or 3 Subject has voluntarily signed and dated the informed consent document approved by the IRB Be English speaking

Exclusion Criteria:

  • Age > 80 years old or younger than 18 years old Congestive heart failure Hepatic insufficiency Neurological disorders Psychiatric disorders Steroid treatment No history of atrial fibrillation Chronic pain disorder with opioid treatment
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01108562

Sponsors and Collaborators
Loma Linda University
Charles Lee MD
Michelle Schlunt MD
Principal Investigator: Michelle L Schlunt, MD Loma Linda University Medical Center
  More Information

Responsible Party: Loma Linda University Identifier: NCT01108562     History of Changes
Other Study ID Numbers: 57366
Study First Received: April 20, 2010
Last Updated: April 2, 2015

Keywords provided by Loma Linda University:
postoperative pain management

Additional relevant MeSH terms:
Pain, Postoperative
Neurologic Manifestations
Nervous System Diseases
Postoperative Complications
Pathologic Processes
Signs and Symptoms
Anesthetics, Local
Central Nervous System Depressants
Physiological Effects of Drugs
Sensory System Agents
Peripheral Nervous System Agents
Anti-Arrhythmia Agents
Voltage-Gated Sodium Channel Blockers
Sodium Channel Blockers
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action processed this record on April 28, 2017